Background More than 90% of the adult population globally is chronically infected by the
Epstein–Barr virus (EBV). It is well established that EBV is associated with a number of …

Peripheral T cell lymphomas (PTCLs) are a heterogeneous group of orphan neoplasms.
Despite the introduction of anthracycline-based chemotherapy protocols, with or without …

The World Health Organization classification of non‐Hodgkin lymphoma (NHL) was
introduced in 2001. However, its incorporation into clinical practice is not well‐described …

Abstract Background Non-Hodgkin lymphoma (NHL) comprises biologically and clinically
heterogeneous subtypes. Previously, study size has limited the ability to compare and …

Purpose Despite an increasing understanding of the pathology and genetics of non-Hodgkin
lymphoma (NHL), global reports on variations in the incidence of NHL remain limited in their …

In 2016 there were an estimated 7,460 newly diagnosed patients with marginal zone
lymphoma (MZL) in the US, which comprised 7% of all mature non-Hodgkin lymphomas …

As the most common non-Hodgkin lymphoma subtype, diffuse large B-cell lymphoma
(DLBCL) incidence patterns generally parallel that for NHL overall. Globally, DLBCL …

Marginal zone lymphoma (MZL) is an indolent B-cell malignancy with heterogeneous
anatomical and clinical presentation. While MZLs are generally associated with long …

Non-Hodgkin lymphoma (NHL) is one of the most common hematologic malignancies
worldwide. The incidence of NHL has been rising for several decades; however, in the last …

Objectives: Describe the pathophysiology of the B cell lymphomas. Review the workup of the
patients with lymphoma. Outlines the treatment of B cell lymphomas, as it depends not only …